子宫颈发育不良市场（依诊断类型、最终使用者和地区）

2025 年全球子宫颈发育不良市场规模估计为 8.222 亿美元，预计到 2032 年将达到 13.64 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.5%。

数字。 2025年子宫颈发育不良市场占有率（按地区划分）

子宫颈发育不良是子宫颈（子宫开口）内壁细胞的癌前病变。这些变化是透过对骨盆检查期间从子宫颈采集的细胞样本进行显微分析来检测的。鳞状上皮内病变是一个病理学术语，指从子宫颈采集的细胞抹片样本中看到的子宫颈发育不良。子宫颈发育不良是由人类乳突病毒 (HPV) 感染引起的。 HPV 是一种非常常见的感染疾病，透过性接触传染。大多数新的 HPV 感染发生在年轻女性（15-25 岁）。大多数 HPV感染疾病不会引起症状并且会自行消失。

市场动态

预计主要市场参与企业不断增加的有机策略将在预测期内推动市场成长。例如，2021年3月1日，专注于推出精准设计的去氧核糖核酸（DNA）药物，用于治疗和预防感染疾病、癌症和HPV相关疾病的生物技术公司Inovio宣布，其REVEAL 1测试的所有可评估受试者均达到了主要和次要终点。该测试是两项正在进行的关键、随机、双盲、多中心、安慰剂对照的 3 期研究之一，使用我们专有的 Selectra 5 PSP 设备评估 VGX-3100 在 HPV-16/18 相关子宫颈高级别鳞状上皮内病变 (HSIL) 中的安全性、耐受性和有效性。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 加强政府努力
• 全球子宫颈发育不良盛行率不断上升
  • 限制因素
• 开发中国家缺乏意识
  • 机会
• 增加政府资金
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 合併、收购和合作

第四章子宫颈发育不良市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 子宫颈发育不良市场（依诊断类型），2020 年至 2032 年

• 介绍
• 诊断测试
• HPV检测
• 子宫颈抹片抹片检查
• 切片检查检查
• 诊断设备
• 窥器

6. 子宫颈发育不良市场（依最终使用者划分），2020 年至 2032 年

• 介绍
• 医院
• 诊断中心
• 门诊手术中心

第七章子宫颈发育不良市场（按地区划分，2020-2032 年）

• 介绍
• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第八章 竞争态势

• 公司简介
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

第九章 章节

• 参考
• 调查方法
• 关于出版商

Global Cervical Dysplasia Market is estimated to be valued at USD 822.2 Mn in 2025 and is expected to reach USD 1,364. Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.

Figure. Cervical Dysplasia Market Share (%), By Region 2025

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

• By Diagnosis Type
  • Diagnosis Test
  • HPV Test
  • Pap Smear Test
  • Biopsy Test
  • Diagnostic Device
  • Colposcope
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Diagnosis Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing government initiatives
• Growing prevalence of cervical dysplasia globally
  • Restraints
• Lack of awareness in developing nations
  • Opportunities
• Increasing government funding
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnosis Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• HPV Test
• Pap Smear Test
• Biopsy Test
• Diagnostic Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Colposcope

6. Cervical Dysplasia Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Company Profile
  • Roche
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Qiagen
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Abbott Laboratories
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical
  • Analyst Views

9. Section

• References
• Research Methodology
• About us